Japan
Join Manufacturing Technology Association of Biologics at BPI Asia 2020
Featured MAB Presentation
Made-In-Japan Platform Technology For Therapeutic Antibody Manufacturing-Perspective For Project MAB
The Manufacturing Technology Association of Biologics (MAB) developed integrated technology platforms for the biologics production. Technology Association is non-profit mutual benefit organization (cooperation) and this association focused on manufacturing of biologics including therapeutic antibody, recombinant protein, and gene therapy. In this presentation, we will introduce the research and developments under AMED project in manufacturing technologies for therapeutic protein.
Presenter: Sei Murakami, Managing Director at Manufacturing Technology Association of Biologics
About MAB
Manufacturing Technology Association of Biologics (Japan) is where next-generation production technologies for biopharmaceuticals are developed, including monoclonal antibodies and cell & gene therapeutics manufacturing.